Editorial

Weight gain on dolutegravir: Association is not the same as causation

Gary Maartens, Phumla Sinxadi, W.D. Francois Venter
Southern African Journal of HIV Medicine | Vol 24, No 1 | a1500 | DOI: https://doi.org/10.4102/sajhivmed.v24i1.1500 | © 2023 Gary Maartens, Phumla Sinxadi, W.D. Francois Venter | This work is licensed under CC Attribution 4.0
Submitted: 31 March 2023 | Published: 15 May 2023

About the author(s)

Gary Maartens, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
Phumla Sinxadi, Division of Clinical Pharmacology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
W.D. Francois Venter, Ezintsha, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

Abstract

No abstract available.

Keywords

dolutegravir; integrase strand transfer inhibitors; weight gain; obesity; efavirenz

Metrics

Total abstract views: 1762
Total article views: 2225

 

Crossref Citations

1. Assessment of weight gain in adult patients living with HIV receiving first‐line dolutegravir‐based or efavirenz‐based ART regimens in routine care clinics in Tshwane district, South Africa: An observational study
Shobna Sawry, Kassahun Ayalew, Gloria Maimela, Melissa Briggs‐Hagen, Marelize van Wyk‐Heath, Simangele Mthethwa, Sannie Shai, Nkululeko N. Mngomezulu, Lawrence Tlhowe, Josephine Achere‐Darko, Jason Bedford, Catherine E. Martin, Lee Fairlie, John Imrie
HIV Medicine  year: 2024  
doi: 10.1111/hiv.13638